Joe Bress

Joe Bress is a Partner and Global Co-Head of Healthcare. He is based in Los Angeles.

Since joining Alfa in 2007, Mr. Bress has been involved in investing and managing over $5 billion of equity investments in healthcare companies globally. He is currently a member of the boards of Acentra Health, Curia, CorroHealth, Launch Therapeutics, Millicent Pharma, Orsini Specialty Pharmacy, Saama Technologies, TriNetX, and WellDyneRx. He is also involved in Alfa's broader life sciences efforts, including the acquisition of Abingworth, as well as Alfa's investments in Included Health and Rede D’Or Sao Luiz. He was previously a member of the boards of Pharmaceutical Product Development (PPD), Visionary RCM, and X-Chem. Prior to Alfa, Mr. Bress worked in the Mergers & Acquisitions group at UBS.

He received an MBA from Stanford University’s Graduate School of Business and an AB from Harvard College, where he graduated magna cum laude.